ADK — Diagnos Income Statement
0.000.00%
Last trade - 00:00- CA$34.50m
- CA$36.16m
- CA$0.10m
Annual income statement for Diagnos, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.267 | 0.439 | 0.486 | 0.17 | 0.104 |
| Cost of Revenue | |||||
| Gross Profit | -0.348 | -0.418 | -0.307 | -0.838 | -0.944 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.55 | 3.1 | 2.72 | 2.78 | 3.93 |
| Operating Profit | -2.28 | -2.66 | -2.24 | -2.61 | -3.82 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.05 | -2.61 | -2.48 | -3.12 | -4.29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.05 | -2.61 | -2.48 | -3.12 | -4.29 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.05 | -2.61 | -2.48 | -3.12 | -4.29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.05 | -2.61 | -2.48 | -3.12 | -4.29 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.033 | -0.038 | -0.036 | -0.043 | -0.049 |